Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
MediciNova, Inc. (MNOV) had Stock-Based Compensation of $0.83M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.15M |
|
$-2.80M |
|
$0.15M |
|
$0.00M |
|
$3.24M |
|
$-3.09M |
|
$0.30M |
|
$-2.80M |
|
$-2.80M |
|
$-2.80M |
|
$-2.80M |
|
$-2.80M |
|
$-2.80M |
|
$-3.09M |
|
$-3.09M |
|
49.06M |
|
49.06M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$30.99M |
|
$0.01M |
|
$14.61M |
|
$45.60M |
|
$3.80M |
|
-- |
|
$0.22M |
|
$4.02M |
|
$41.59M |
|
$31.99M |
|
$41.59M |
|
49.22M |
|
| Cash Flow Statement Financials | |
$-9.81M |
|
$-0.00M |
|
$0.24M |
|
$40.36M |
|
$30.81M |
|
$-9.55M |
|
|
Stock-Based Compensation |
$0.83M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
3.13% |
|
-2037.97% |
|
-2037.97% |
|
-- |
|
-1842.83% |
|
-1846.78% |
|
$-9.81M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-6.74% |
|
-8.76% |
|
-6.14% |
|
-6.74% |
|
$0.84 |
|
$-0.20 |
|
$-0.20 |
|